Brief: Hepion Pharmaceuticals Announces USAN Selection Of "Rencofilstat" As Nonproprietary Name For CRV431
06/01/2022 22:34
Jan 6 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS ANNOUNCES USAN SELECTION OF
"RENCOFILSTAT" AS NONPROPRIETARY NAME FOR CRV431
* HEPION PHARMACEUTICALS INC- GOING FORWARD, HEPION WILL USE
NAME
"RENCOFILSTAT" IN UPCOMING PUBLICATIONS, PUBLIC STATEMENTS,
OTHER FORUMS FOR CRV431
Source text for Eikon: ID:nGNX6cgJ5K
Further company coverage: HEPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement